Editorial Comment: Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity.
作者信息
Averbeck Marcio Augusto
机构信息
Chefe de Neuro-Urologia, Unidade de Videourodinâmica, Hospital Moinhos de Vento. Porto Alegre, RS, Brasil.
出版信息
Int Braz J Urol. 2021 Mar-Apr;47(2):454-455. doi: 10.1590/S1677-5538.IBJU.2021.02.03.
Abstract
摘要
相似文献
1
Editorial Comment: Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity.编者按：膀胱内注射A型肉毒毒素治疗难治性神经源性逼尿肌过度活动的长期疗效及失败风险因素。
Int Braz J Urol. 2021 Mar-Apr;47(2):454-455. doi: 10.1590/S1677-5538.IBJU.2021.02.03.
2
Long-Term Discontinuation of Botulinum Toxin A Intradetrusor Injections for Neurogenic Detrusor Overactivity: A Multicenter Study.长期中断肉毒毒素 A 膀胱内注射治疗神经源性逼尿肌过度活动症：一项多中心研究。
J Urol. 2019 Apr;201(4):769-776. doi: 10.1016/j.juro.2018.10.012.
3
More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.经尿道注射肉毒毒素 A 治疗难治性神经源性逼尿肌过度活动症：15 年以上经验教训。
Eur Urol. 2016 Sep;70(3):522-8. doi: 10.1016/j.eururo.2016.03.052. Epub 2016 Apr 19.
4
Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity.膀胱内注射A型肉毒毒素治疗难治性神经源性逼尿肌过度活动的长期疗效及失败风险因素
Neurourol Urodyn. 2018 Feb;37(2):799-806. doi: 10.1002/nau.23352. Epub 2017 Jul 26.
5
Re: Long-Term Outcomes and Risks Factors for Failure of Intradetrusor Onabotulinumtoxin A Injections for the Treatment of Refractory Neurogenic Detrusor Overactivity.
J Urol. 2019 Apr;201(4):673. doi: 10.1097/01.JU.0000553373.98824.8e.
6
Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity.编者按：神经源性逼尿肌过度活动患者在膀胱逼尿肌内注射肉毒杆菌毒素后使用索利那新治疗。
Int Braz J Urol. 2022 Nov-Dec;48(6):988-989. doi: 10.1590/S1677-5538.IBJU.2022.06.02.
7
Intradetrusor onabotulinumtoxinA injections for refractory neurogenic detrusor overactivity incontinence: do we need urodynamic investigation for outcome assessment?膀胱内注射A型肉毒毒素治疗难治性神经源性逼尿肌过度活动失禁：我们是否需要尿动力学检查来评估疗效？
BJU Int. 2017 Dec;120(6):848-854. doi: 10.1111/bju.13976. Epub 2017 Aug 28.
8
Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment.在未接受抗生素治疗的难治性神经源性逼尿肌过度活动患者中，膀胱逼尿肌肉毒毒素 A 注射后发生尿路感染的风险。
BJU Int. 2010 Dec;106(11):1677-80. doi: 10.1111/j.1464-410X.2010.09435.x.
9
10
Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.肉毒杆菌毒素A（保妥适）膀胱逼尿肌内注射治疗儿童神经源性逼尿肌过度活动症/神经源性膀胱过度活动症：一项系统文献综述
J Pediatr Urol. 2009 Jun;5(3):156-64. doi: 10.1016/j.jpurol.2009.01.005. Epub 2009 Mar 4.
Zotero 插件